Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in STEMI (TIGER Study)
NCT02792712Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by Taipei Veterans General Hospital. Primary endpoints: Myocardial Salvage Index and Cardiac Troponin I at 72 hours. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02792712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02792712.